Among new biotech medicines that Michigan companies are working on:
-- A treatment to repair damaged neural tissue in patients with spinal cord injuries
-- A medicine that treats the effects of anthrax after toxins have been released into the body, a condition for which there is no approved therapy
-- A treatment for menopause that mimics estrogen's beneficial action in bone tissue
"Researchers are making exciting progress in the search for new cures and treatments for a wide array of serious diseases. But these efforts are wasted if the medicines that are developed are not accessible to the patients who need them," said PhRMA President and CEO Billy Tauzin.
Help is available to patients in need through the Partnership for Prescription Assistance (PPA), a program sponsored by America's pharmaceutical research companies. To date, the PPA has helped more than 5 million patients nationwide, including more than 176,087 people in Michigan. Since its launch in April 2005, the PPA bus tour has visited all 50 states and more than 2,000 cities. The PPA bus has been to Michigan nine times since the program was launched.
To read the 2008 report, Medicines in Development Biotechnology, go to: http://www.phrma.org
The Pharmaceutical Research and Manufacturers of America (PhRMA)
represents the country's leading pharmaceutical research and biotechnology
companies, which are devoted to inventing medicines that allow patients to
live longer, healthier, and more productive lives. PhRMA comp
|SOURCE Pharmaceutical Research and Manufacturers of America|
Copyright©2008 PR Newswire.
All rights reserved